Medifast Is Maintained at Underperform by DA Davidson
Medifast Is Maintained at Underperform by DA
Medifast Price Target Maintained With a $17.50/Share by DA Davidson
Medifast Price Target Maintained With a $17.50/Share by DA
Express News | DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Maintains Target Price $17.5
D.A. Davidson analyst Linda Bolton Weiser maintains $Medifast(MED.US)$ with a sell rating, and maintains the target price at $17.5.According to TipRanks data, the analyst has a success rate of 44.8%
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
Medifast, Inc.'s (NYSE:MED) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Personal Care Stocks Q1 Teardown: Medifast (NYSE:MED) Vs The Rest
Medifast Named as One of The "Best Companies To Work For" by U.S. News & World Report
Company recognized as one of the best employers in the food and drink industry for 2024-2025 Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution
Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24
KKR (KKR), CrowdStrike (CRWD), and GoDaddy (GDDY) will replace Robert Half (RHI), Comerica (CMA), and Illumina (ILMN) in the S&P 500 index from June 24, S&P Dow Jones Indices said on Friday. Illumina
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to Join S&P 600
Street Calls of the Week: Upgrades for Best Buy and Lululemon
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the ...
Medifast Falls 15% Following DA Davidson Downgrade
Express News | MEDIFAST Shares Are Trading Lower After DA Davidson Downgraded the Stock From Neutral to Underperform and Lowered Its Price Target From $25 to $17.5
Medifast Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/05/2024 -14.22% DA Davidson $25 → $17.5 Downgrades Neutral → Underperform 04/30/2024 22.55% DA Davidson
Express News | Medifast Inc : D.a. Davidson Cuts Target Price to $17.5 From $25